News - Licensing

Filter

Current filters:

Licensing

Popular Filters

151 to 175 of 978 results

TaiGen Biotech signs up deal for Taigexyn in Russia and other states

15-01-2014

Taiwan-based drug developer TaiGen Biotechnology has signed an exclusive agreement with R-Pharm, a leading…

Antibiotics and Infectious diseasesEastern EuropeLicensingnemonoxacinPharmaceuticalR-PharmRussiaTaiGen BiotechTaigexynTurkey

Helsinn and Angelini ink licensing deal for anamorelin

15-01-2014

Privately-held Swiss pharma group Helsinn has granted exclusive distribution and licensing rights for…

anamorelinAngeliniEastern EuropeHelsinnLicensingOncologyPharmaceutical

Alexion inks deal with Moderna for rare diseases; “deal of the year” say analysts

Alexion inks deal with Moderna for rare diseases; “deal of the year” say analysts

15-01-2014

US drugmaker Alexion Pharmaceuticals has signed an exclusive strategic agreement with privately-held…

Alexion PharmaceuticalsLicensingModerna TherapeuticsPharmaceuticalRare diseases

Jazz Pharma in $397 million deal with Aerial for narcolepsy drug ADX-NO5

14-01-2014

Ireland-headquartered drugmaker Jazz Pharmaceuticals has inked an agreement with the USA’s Aerial BioPharma…

ADX-NO5Aerial BioPharmaGlobalJazz PharmaceuticalsLicensingNeurologicalPharmaceutical

Galena Biopharma links with and Dr Reddy's for NeuVax in India

14-01-2014

USA-based Galena Biopharma and India’s second-largest drugmaker Dr Reddy's Laboratories have entered…

Asia-PacificDr Reddy's LaboratoriesGalena BioPharmaIndiaLicensingNeuVaxOncologyPharmaceutical

NantBioScience enters cancer collaboration with Celgene

NantBioScience enters cancer collaboration with Celgene

14-01-2014

USA-based NantBioScience, a subsidiary of privately-held NantWorks, has entered into a strategic collaboration…

AbraxaneBiotechnologyCelgeneLicensingNantBioSciencesNTB-010NTB-011OncologyResearch

Ipsen and GW Pharma to promote Sativex in Latin America; Ipsen will ‘go it alone’ for Somatuline

Ipsen and GW Pharma to promote Sativex in Latin America; Ipsen will ‘go it alone’ for Somatuline

14-01-2014

French drugmaker Ipsen (Euronext: IPN) and UK-based GW Pharmaceuticals (Nasdaq: GWPH) have entered into…

FranceGW PharmaceuticalsIpsenLicensingPharmaceuticalSativexSomatuline

Regeneron and Bayer expand deal to develop new option for wet-AMD

Regeneron and Bayer expand deal to develop new option for wet-AMD

14-01-2014

US biotech firm Regeneron Pharmaceuticals said yesterday that it has expanded its accord with German…

BayerBiotechnologyEyleaLicensingOphthalmicsRegeneronResearch

GlaxoSmithKline returns Duchenne drug rights to Prosensa

GlaxoSmithKline returns Duchenne drug rights to Prosensa

13-01-2014

UK pharma giant GlaxoSmithKline says that its partner, Dutch biotech firm Prosensa has regained all rights…

BiotechnologydrisapersenGlaxoSmithKlineLicensingProsensaRare diseases

Cell Therapeutics to reacquire rights to two anti-cancer compounds

13-01-2014

US biotech firm Cell Therapeutics says it has reached an agreement with partner Novartis to reacquire…

BiotechnologyCell TherapeuticsLicensingNovartisOncologyOpaxioPixuvri

Lilly buys back CGRP antibody for migraine prevention from Arteaus Therapeutics

Lilly buys back CGRP antibody for migraine prevention from Arteaus Therapeutics

13-01-2014

Based on positive Phase II data, US drug major Eli Lilly has acquired all development rights for a calcitonin…

Arteaus TherapeuticsEli LillyLicensingLY2951742NeurologicalPharmaceutical

Genzyme to gain rights to certain Alnylam rare disease pipeline products

Genzyme to gain rights to certain Alnylam rare disease pipeline products

13-01-2014

French drug major Sanofi’s US biotech subsidiary Genzyme and Alnylam Pharmaceuticals have significantly…

Alnylam PharmaceuticalsBiotechnologyGenzymeLicensingMergers & AcquisitionspatisiranRare diseasesResearchSanofi

Santaris Pharma in deal with GlaxoSmithKline to develop RNA-targeted medicines

Santaris Pharma in deal with GlaxoSmithKline to develop RNA-targeted medicines

13-01-2014

Santaris Pharma, a Denmark-based clinical-stage biopharma company, has signed an agreement with UK drug…

GlaxoSmithKlineLicensingPharmaceuticalSantaris Pharma

Mersana Therapeutics reaches second preclinical milestone in Endo collaboration

10-01-2014

Privately-held US biotech company Mersana Therapeutics has achieved its second preclinical milestone…

BiotechnologyEndo PharmaceuticalsFinancialLicensingMersanaOncologyResearchUSA

FORMA meets milestones under Boehringer Ingelheim cancer accord

FORMA meets milestones under Boehringer Ingelheim cancer accord

10-01-2014

US drug discovery company FORMA Therapeutics revealed that it has achieved several discovery milestones…

Boehringer IngelheimFORMA TherapeuticsLicensingOncologyPharmaceuticalResearch

Nuevolution signs licensing agreement with Novartis

Nuevolution signs licensing agreement with Novartis

10-01-2014

Denmark-based Nuevolution has entered into a non-exclusive technology licensing agreement with Swiss…

BiotechnologyDenmarkGeneticsLicensingNorthern EuropeNovartisNuevolutionResearch

Biogen Idec and Sangamo BioSciences collaborate on blood disorder therapeutics

Biogen Idec and Sangamo BioSciences collaborate on blood disorder therapeutics

10-01-2014

US biotech firm Biogen Idec and Sangamo Biosciences have signed an exclusive worldwide collaboration…

Biogen IdecBiotechnologyHematologyLicensingResearchSangamo BioSciences

Santaris inks deal with Roche for RNA-targeted medicines

Santaris inks deal with Roche for RNA-targeted medicines

09-01-2014

Danish privately held clinical-stage biopharmaceutical company Santaris Pharma has signed a worldwide…

LicensingPharmaceuticalResearchRocheSantaris Pharma

Evestra signs research accord with Gedeon Richter

Evestra signs research accord with Gedeon Richter

09-01-2014

Privately-held US firm Evestra says it has signed a collaboration partnership agreement with Hungary’s…

EvestraGedeon RichterLicensingPharmaceuticalReproductiveResearch

Allergan closes $65 million deal with Medytox

Allergan closes $65 million deal with Medytox

09-01-2014

This week US drugmaker Allergan (NYSE: AGN) announced that it has closed a $65 million license agreement…

AllerganAsia-PacificBotoxDermatologicalsLicensingMedytoxPharmaceuticalRegulationUKUSA

CytomX and ImmunoGen announce collaboration to develop Probody-Drug Conjugates against cancer targets

09-01-2014

US biotech firms CytomX Therapeutics and ImmunoGen (Nasdaq: IMGN) have signed a collaboration agreement…

BiotechnologyCytomX TherapeuticsImmunoGenLicensingOncologyResearchUSA

Isarna Therapeutics enters into a strategic manufacturing agreement with Sanofi

Isarna Therapeutics enters into a strategic manufacturing agreement with Sanofi

09-01-2014

German drug developer Isarna Therapeutics has signed a strategic manufacturing agreement with Sanofi…

FranceGermanyImmunologicalsIsarna TherapeuticsLicensingPharmaceuticalProductionSanofi

Seattle Genetics expands cancer drug collaboration with AbbVie

Seattle Genetics expands cancer drug collaboration with AbbVie

09-01-2014

US biotech firm Seattle Genetics says it has further expanded its antibody-drug conjugate (ADC) collaboration…

AbbVieBiotechnologyLicensingOncologySeattle Genetics

151 to 175 of 978 results

Back to top